CAS: 677702-23-7 - Boronic acid, B-4-isoquinolinyl-, hydrochloride (1:1)
Formula:C9H8BNO2·ClH
InChI:InChI=1S/C9H8BNO2.ClH/c12-10(13)9-6-11-5-7-3-1-2-4-8(7)9;/h1-6,12-13H;1H
InChI key:InChIKey=KVBIOGMRHMKPFZ-UHFFFAOYSA-N
SMILES:Cl.OB(O)C1=CN=CC2=CC=CC=C21
- Synonyms:
- Boronic acid, 4-isoquinolinyl-, hydrochloride
- Boronic acid, B-4-isoquinolinyl-, hydrochloride (1:1)
- Isoquinolin-4-ylboronic acid hydrochloride
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Isoquinoline-4-boronic acid hydrochloride REF: IN-DA003R5JCAS: 677702-23-7 | 97% | To inquire | Tue 21 Jan 25 | |
Isoquinolin-4-ylboronic acid, hydrochloride REF: 54-OR908294CAS: 677702-23-7 | 98+% | 32.00 €~954.00 € | Tue 28 Jan 25 | |
ISOQUINOLINE-4-BORONIC ACID HCL REF: 10-F474964CAS: 677702-23-7 | 95.0% | To inquire | Fri 31 Jan 25 | |
Isoquinolin-4-ylboronic acid, HCl REF: 3D-FI160627CAS: 677702-23-7 | Min. 95% | - - - | Discontinued product |
Isoquinoline-4-boronic acid hydrochloride
CAS:677702-23-7
Formula:
C9H9BClNO2
Purity:
97%
Color and Shape:
Solid
Molecular weight:
209.4373
Ref: IN-DA003R5J
1g | 61.00 € | ||
5g | 144.00 € | ||
25g | 526.00 € | ||
100g | To inquire | ||
250mg | 39.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 54-OR908294
1g | 32.00 € | ||
5g | 105.00 € | ||
25g | 364.00 € | ||
100g | 954.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Ref: 10-F474964
1g | To inquire | ||
5g | To inquire | ||
25g | To inquire | ||
100g | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Friday 31 Jan 2025
Isoquinolin-4-ylboronic acid, HCl
CAS:677702-23-7
Please enquire for more information about Isoquinolin-4-ylboronic acid, HCl including the price, delivery time and …
Formula:
C9H8BNO2·ClH
Purity:
Min. 95%
Molecular weight:
209.44 g/mol
Ref: 3D-FI160627
2g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
25g | Discontinued | Request information | |
50g | Discontinued | Request information |